Ayano Hiroshima

T‐0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor‐deficient mice

Naoki Terasaka, Ayano Hiroshima, Tadashi Koieyama et al. · FEBS Letters · 2002 · 322 citations

Liver X receptor agonists inhibit tissue factor expression in macrophages

Naoki Terasaka, Ayano Hiroshima, Akiko Ariga et al. · FEBS Journal · 2005 · 67 citations · Full text

Immune Regulation, Immunology, Pathology +20

LXRα regulates human CETP expression in vitro and in transgenic mice

Shoko Honzumi, Akiko Shima, Ayano Hiroshima et al. · Atherosclerosis · 2010 · 36 citations

Transcriptional Regulation, Developmental Biology, Signal Transduction +10

Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits

Shoko Honzumi, Akiko Shima, Ayano Hiroshima et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2011 · 24 citations

Inflammation, Metabolic Syndrome, Vascular Disease +10

Overexpression of Bop3 confers resistance to methylmercury in Saccharomyces cerevisiae through interaction with other proteins such as Fkh1, Rts1, and Msn2

Gi‐Wook Hwang, Yuko Furuoya, Ayano Hiroshima et al. · Biochemical and Biophysical Research Communications · 2005 · 11 citations

Bop3 Confers Resistance, Other Proteins, Natural Sciences +9